Methodology of the brodalumab assessment of hazards: a multicentre observational safety (BRAHMS) study

Methodology of the brodalumab assessment of hazards: a multicentre observational safety (BRAHMS) study

Introduction Safe and effective pharmacological treatment is of paramount importance for treating severe psoriasis. Brodalumab, a monoclonal antibody against interleukin (IL) 17 receptor A, was granted marketing authorisation in the EU in 2017. The European Medicines Agency requested a postauthorisa...

Full description

Saved in:
Bibliographic Details
Main Authors: Øystein Karlstad, Alexander Egeberg, Kari Furu, Ulrike Haug, Wiebke Schäfer, Johan Reutfors, Mette Reilev, Jesper Hallas, Ron Herings, Valeria Belleudi, Gianluca Trifirò, Rosa Gini, Ursula Kirchmayer, Henrik Støvring, Peter Bjødstrup Jensen, Lise Skov Ranch, Karin Gembert, David Hagg, Sarina Schwartz, Elisabeth Smits, Emily Holthius, Alessandro Cesare Rosa
Format: Article
Language:English
Published: BMJ Publishing Group 2023-02-01
Series:BMJ Open
Online Access:https://bmjopen.bmj.com/content/13/2/e066057.full
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://bmjopen.bmj.com/content/13/2/e066057.full

Similar Items